Concepedia

Publication | Open Access

STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma

122

Citations

26

References

2010

Year

Abstract

Our results suggest that using WP1066 to inhibit the STAT3 signalling pathway could be a novel therapeutic strategy against RCC.

References

YearCitations

Page 1